Skip to main content
Journal cover image

INTERFERON alpha-2B BY CONTINUOUS SUBCUTANEOUS INFUSION IN COMBINATION WITH RIBAVIRIN FOR TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS: 12 WEEK INTERIM ANALYSIS

Publication ,  Conference
Muir, AJ; Bacon, BR; Gitlin, N; Kugelmas, M; Tillman, HL; Grovender, EA; Van Antwerp, B; Mische, S; Kwo, PY
Published in: HEPATOLOGY
October 1, 2011

Duke Scholars

Published In

HEPATOLOGY

ISSN

0270-9139

Publication Date

October 1, 2011

Volume

54

Start / End Page

1439A / 1439A

Location

San Francisco, CA

Publisher

WILEY-BLACKWELL

Conference Name

62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Muir, A. J., Bacon, B. R., Gitlin, N., Kugelmas, M., Tillman, H. L., Grovender, E. A., … Kwo, P. Y. (2011). INTERFERON alpha-2B BY CONTINUOUS SUBCUTANEOUS INFUSION IN COMBINATION WITH RIBAVIRIN FOR TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS: 12 WEEK INTERIM ANALYSIS. In HEPATOLOGY (Vol. 54, pp. 1439A-1439A). San Francisco, CA: WILEY-BLACKWELL.
Muir, Andrew J., Bruce R. Bacon, Norman Gitlin, Marcelo Kugelmas, Hans L. Tillman, Eric A. Grovender, Bill Van Antwerp, Sarah Mische, and Paul Y. Kwo. “INTERFERON alpha-2B BY CONTINUOUS SUBCUTANEOUS INFUSION IN COMBINATION WITH RIBAVIRIN FOR TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS: 12 WEEK INTERIM ANALYSIS.” In HEPATOLOGY, 54:1439A-1439A. WILEY-BLACKWELL, 2011.
Muir AJ, Bacon BR, Gitlin N, Kugelmas M, Tillman HL, Grovender EA, et al. INTERFERON alpha-2B BY CONTINUOUS SUBCUTANEOUS INFUSION IN COMBINATION WITH RIBAVIRIN FOR TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS: 12 WEEK INTERIM ANALYSIS. In: HEPATOLOGY. WILEY-BLACKWELL; 2011. p. 1439A-1439A.
Muir AJ, Bacon BR, Gitlin N, Kugelmas M, Tillman HL, Grovender EA, Van Antwerp B, Mische S, Kwo PY. INTERFERON alpha-2B BY CONTINUOUS SUBCUTANEOUS INFUSION IN COMBINATION WITH RIBAVIRIN FOR TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS: 12 WEEK INTERIM ANALYSIS. HEPATOLOGY. WILEY-BLACKWELL; 2011. p. 1439A-1439A.
Journal cover image

Published In

HEPATOLOGY

ISSN

0270-9139

Publication Date

October 1, 2011

Volume

54

Start / End Page

1439A / 1439A

Location

San Francisco, CA

Publisher

WILEY-BLACKWELL

Conference Name

62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics